Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

Midlands and North West
21 May 2013 18:45



Northern England
21 May 2013 18:03



National Team Build
21 May 2013 18:01


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Testimonials
Thank you for your help with my job search. From the beginning of my search, my Account Manager and the Zenopa team matched me up with the correct opportunities and guided me through the whole process...
Rory, 2013

BioMerieux reports continued growth in first half of 2012

26 July 2012 16:29 in Scientific Company News


BioMerieux has reported positive business growth in the first half of 2012, with net sales for the period coming to 750 million euros (587.53 million pounds).

This was up from 673 million euros in the corresponding period of 2011, representing a rise of 8.7 percent in constant currency terms, while second-quarter sales rose to 388 million euros thanks to a major improvement in Asia-Pacific revenues.

According to the firm, the strong performance seen in emerging markets is indicative of the advantages of BioMerieux's balanced geographic footprint.

Top-performing operations include the Full Microbiology Lab Automation range and the company's industrial applications division, with the July 2011 acquisition of AES Laboratoire aiding this growth.

Jean-Luc Belingard, chairman and chief executive officer at BioMerieux, said: "In the current economic environment, our sales growth objective for 2012 remains unchanged."

In May 2012, the company expanded its product range with the launch of a new Vidas hepatitis C diagnostic test.ADNFCR-8000103-ID-801416194-ADNFCR

Other news stories from 26/07/2012

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd